glp-1 agonist and heart failure Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes GLP-1 agonists for heart failure:

Gallbladder Issues Research shows an increase in gallbladder-related issues in GLP-1 medication users, with conditions ranging from asymptomatic gallstones to severe cholecystitis requiring surgical intervention

And then you found out what GLP-1s actually cost without insurance ($900 $1,500 per month at retail pharmacies) and the number stopped you cold

doi: 10.1210/jc.2003-031403 [DOI] [PubMed] [Google Scholar] 38.Muskiet MH Tonneijck L Smits MM, et al

doi: 10.1016/S0140-6736(19)31149-3 55 GastaldelliACusiKFernndez LandLBrayRBrouwersBRodrguez

Novo nordisk files for regulatory approval of once-weekly semaglutide with the fda for the treatment of type 2 diabetes